Drug
Nanoparticle Albumin-Bound Docetaxel clinical trials
A product of Docetaxel; its studies count on that page too.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses Nanoparticle Albumin-Bound Docetaxel is read from its arms, and is right about nine times in ten.
Testing it · 3
- Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid TumorsTerminatedPhase 1Conjupro Biotherapeutics, Inc.NCT04931823Written as CPO-100
- ABI-008 Trial in Patients With Hormone-refractory Prostate CancerCompletedPhase 1/2CelgeneNCT00477529Written as ABI-008
- ABI-008 Trial in Patients With Metastatic Breast CancerTerminatedPhase 1/2CelgeneNCT00531271Written as ABI-008 (nab-docetaxel)